Show simple item record

dc.contributor.authorYounger, Een_US
dc.contributor.authorHusson, Oen_US
dc.contributor.authorBennister, Len_US
dc.contributor.authorWhelan, Jen_US
dc.contributor.authorWilson, Ren_US
dc.contributor.authorRoast, Aen_US
dc.contributor.authorJones, RLen_US
dc.contributor.authorvan der Graaf, WTen_US
dc.coverage.spatialEnglanden_US
dc.date.accessioned2019-02-20T08:14:45Z
dc.date.issued2018-10-17en_US
dc.identifierhttps://www.ncbi.nlm.nih.gov/pubmed/30333006en_US
dc.identifier10.1186/s12885-018-4866-8en_US
dc.identifier.citationBMC Cancer, 2018, 18 (1), pp. 991 - ?en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3070
dc.identifier.eissn1471-2407en_US
dc.identifier.doi10.1186/s12885-018-4866-8en_US
dc.description.abstractBACKGROUND: Sarcomas are rare, heterogeneous tumours affecting patients of any age. Previous surveys describe that sarcoma patients report a significantly worse experience than those with common cancers. Consequently, Sarcoma UK conducted a national survey and these data were examined for age- and tumour-related differences in patients' experiences. METHODS: Patients were randomly selected from respondents to National Cancer Patient Experience Surveys (n = 900). Differences between patient groups according to age (Adolescents and Young Adults [AYA] 18-39 years, middle-aged 40-64 years, elderly 65 + years) and tumour type (soft-tissue [STS] vs. bone]) were analysed with t-tests or chi-square tests. RESULTS: Survey response rate was 62% (n = 558; STS 75%, bone sarcoma 25%). Delay in diagnosis was reported; 27% patients (n = 150) waited > 3 months and initial symptoms were incorrectly interpreted; AYA STS patients were significantly more likely to be treated for another condition, or advised that their symptoms were not serious, than older STS patients. Clinical trial participation was low (6%, n = 35). Symptom burden was high, most commonly daytime fatigue (48%, n = 277) and pain (44%, n = 248). AYAs were significantly more likely to report most side-effects and post-treatment concerns than older patients. Elderly patients were more satisfied with the information and emotional support provided than younger patients, however were significantly less likely to be referred to rehabilitation services. CONCLUSIONS: This study identifies significant age-related differences in the sarcoma patient journey, which are not only related to variation in tumour-types. These results provide rationale for adopting an age-specific approach to the management of sarcoma patients in order to improve overall patient experience.en_US
dc.format.extent991 - ?en_US
dc.languageengen_US
dc.language.isoengen_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/wden_US
dc.subjectAdolescents and young adultsen_US
dc.subjectAge-relateden_US
dc.subjectElderlyen_US
dc.subjectPatient experienceen_US
dc.subjectSarcomaen_US
dc.subjectAdolescenten_US
dc.subjectAdulten_US
dc.subjectAge Factorsen_US
dc.subjectAgeden_US
dc.subjectAged, 80 and overen_US
dc.subjectCross-Sectional Studiesen_US
dc.subjectEnglanden_US
dc.subjectFemaleen_US
dc.subjectFollow-Up Studiesen_US
dc.subjectHumansen_US
dc.subjectMaleen_US
dc.subjectMiddle Ageden_US
dc.subjectOsteosarcomaen_US
dc.subjectSarcomaen_US
dc.subjectSoft Tissue Neoplasmsen_US
dc.subjectSurveys and Questionnairesen_US
dc.subjectYoung Adulten_US
dc.titleAge-related sarcoma patient experience: results from a national survey in England.en_US
dc.typeJournal Article
dcterms.dateAccepted2018-09-26en_US
rioxxterms.versionofrecord10.1186/s12885-018-4866-8en_US
rioxxterms.licenseref.startdate2018-10-17en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfBMC Canceren_US
pubs.issue1en_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical and Translational Sarcoma
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials (R Jones)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials (R Jones)/Sarcoma Clinical Trials (R Jones) (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished onlineen_US
pubs.volume18en_US
pubs.embargo.termsNot knownen_US
icr.researchteamClinical and Translational Sarcomaen_US
icr.researchteamSarcoma Clinical Trials (R Jones)en_US
dc.contributor.icrauthorJones, Robinen_US
dc.contributor.icrauthorHusson, Olgaen_US
dc.contributor.icrauthorvan der Graaf, Wilhelminaen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/wd
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/wd